Researchers adapted optical diffusion technology in a low-cost portable device to assess microvascular blood flow in human skin and showed proof of concept in early detection of diabetic neuropathy.
The rise in diabetic neuropathy over the last few decades has paralleled the obesity and related diabetes pandemics, one expert says, and neurologists have a role to play in controlling it.
The Diabetes Control and Complications Trial (DCCT) and its follow-on observational study EDIC continue to provide new insights into type 1 diabetes as the study participants age.
Zelira Therapeutics cannabinoid-based drug may be a safe, effective, and well-tolerated alternative to pregabalin for diabetic neuropathy, the company said.